Twitter | Search | |
This is the legacy version of twitter.com. We will be shutting it down on 15 December 2020. Please switch to a supported browser or device. You can see a list of supported browsers in our Help Center.
OncoHost
OncoHost develops personalized strategies to maximize the success of cancer therapy.
59
Tweets
261
Following
67
Followers
Tweets
OncoHost Dec 3
We are excited to announce that OncoHost CEO, , will be taking part in a historic delegation of Israeli entrepreneurs to the UAE next week! Looking forward to a week of new connections and opportunities!
Reply Retweet Like
OncoHost Nov 26
Wishing everyone a happy, healthy Thanksgiving!
Reply Retweet Like
OncoHost Nov 25
With over 220,000 new cases of lung cancer a year, lung cancer is the third most common cancer in the US. As November is lung cancer awareness month, do your part to help educate others:
Reply Retweet Like
OncoHost Nov 18
“The ability to adequately assess, and potentially predict, response and resistance to immunotherapy will lead to better outcomes for patients,” - the American Society of Clinical Oncology. Read more about our new developments in cancer care & research:
Reply Retweet Like
OncoHost Nov 17
We are proud to see our very own Michal Harel featured in the SITC conference highlights. Check out it out:
Reply Retweet Like
OncoHost Nov 11
Cancer immunotherapy focuses on the immune system and carries a big promise for cancer patients. Therefore, it is crucial when considering a treatment plan, we go beyond the drug-tumor interaction and understand a patient's unique response to treatment.
Reply Retweet Like
OncoHost Nov 9
We are excited to present our most recent study at SITC 2020! The study examines the use of plasma-based proteomic profiling as a clinically insightful tool for oncologists to identify new targets in overcoming treatment resistance. Read more:
Reply Retweet Like
OncoHost Nov 4
Preliminary findings in a recent trial show the use of specific heart drugs boosts the performance of immunotherapy in some patients. These findings show the potential of personalized treatment, and what can be achieved when combining treatments safely.
Reply Retweet Like
OncoHost Nov 2
Immunotherapy can play a significant role in the fight against cancer, but there are also serious side effects including itchy and painful skin reactions. Japanese researchers have discovered the cause of these reactions which could help prevent them.
Reply Retweet Like
OncoHost Oct 29
Our immune system has trouble identifying melanoma cells. New research from the Melanoma Group at the Spanish National Cancer Research Center (CNIO) has discovered how melanoma cells go undetected. Read more:
Reply Retweet Like
OncoHost Oct 28
Lung cancer is the deadliest cancer and accounts for approximately 25% of all cancer deaths. However, with these five areas of research we’re potentially headed towards a future where lung cancer is more treatable and claims fewer lives:
Reply Retweet Like
OncoHost Oct 7
Skepticism surrounding the use of AI in healthcare is fairly widespread, specifically in personalized treatment. However, we need to realize that isn’t here to replace medical professionals, but rather to assist them. Read more here:
Reply Retweet Like
OncoHost Oct 5
We look forward to presenting our data on predicting to at the MAP 2020 Virtual Congress! Join us, Oct. 9th at 17:20PM CEST to see Prof. , co-founder & Chief Scientific Advisor at OncoHost deliver the presentation.
Reply Retweet Like
OncoHost Sep 23
OncoHost co-founder, Professor Yuval Shaked, will be presenting tomorrow, September 24th at Virtual Conference on Lung Cancer at 10:00AM EST. Yuval will discuss “Host Response to Anti-Cancer Therapy and its Clinical Implications”.
Reply Retweet Like
OncoHost Sep 17
We are excited to present new data on host response profiling for NSCLC patients at ESMO Virtual Congress 2020! Read more about our clinical study here:
Reply Retweet Like
OncoHost May 15
According to recent studies immunotherapy has proven to be an effective treatment before surgery for breast cancer patients. The big question is how can we identify the patients that will actually benefit from the treatment
Reply Retweet Like
OncoHost May 14
We're looking forward to sharing new data on Host Response Profiling for Melanoma Patients at the 2020 Annual Meeting! Find out more:
Reply Retweet Like
OncoHost May 12
Global collaborative cancer research initiatives have provided a very large volume of data. As a result, it is crucial to have a system in place to manage and integrate this information turning it into clinical insights.
Reply Retweet Like
OncoHost May 12
The emphasis in the fight against cancer is primarily on treatment. However, the next revolution in cancer management is diagnostics, from early detection to treatment strategies. Precision medicine is the next tsunami in Oncology. Read more:
Reply Retweet Like
OncoHost Apr 27
According to research published in , applying artificial intelligence tools to standard CT scans could help predict tumor response in patients with advanced non-small cell lung cancer. Read more:
Reply Retweet Like